c.zamora
Submits third-party assay reports on material purchased directly. Based in Gdańsk.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.00%
n=6
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041676 | Retatrutide | TFS | TFS-{CAT}-9709 | VendorInvestigate | 2026-Q2 | 97.55 | 3.90 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041237 | Retatrutide | WWB | WWB-2510-H1662 | Janoshik | 2026-Q1 | 99.45 | 4.60 | 107.2 | Buyer-sourced | 0 | PASS |
| AX-2026-043342 | N-Acetyl Semax Amide | WXT | WXT-2505-J2528 | Janoshik | 2025-Q4 | 98.40 | 5.53 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018490 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | Janoshik | 2025-Q4 | 99.17 | 4.10 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018422 | Semaglutide | WWB | WWB-2501-S2183 | Janoshik | 2025-Q1 | 98.84 | 4.07 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004921 | GHRP-2 | GGPeps | GGPE-2406-F1736 | PeptideMeter | 2024-Q4 | 99.23 | 6.19 | — | Buyer-sourced | 0 | PASS |